Literature DB >> 21684170

Clinical results of boron neutron capture therapy (BNCT) for glioblastoma.

T Kageji1, Y Mizobuchi, S Nagahiro, Y Nakagawa, H Kumada.   

Abstract

The purpose of this study was to evaluate the clinical outcome of BSH-based intra-operative BNCT (IO-BNCT) and BSH and BPA-based non-operative BNCT (NO-BNCT). We have treated 23 glioblastoma patients with BNCT without any additional chemotherapy since 1998. The median survival time (MST) of BNCT was 19.5 months, and 2-year, 3-year and 5-year survival rates were 26.1%, 17.4% and 5.8%, respectively. This clinical result of BNCT in patients with GBM is superior to that of single treatment of conventional radiotherapy compared with historical data of conventional treatment. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2011        PMID： 21684170     DOI： 10.1016/j.apradiso.2011.05.029

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN： 0969-8043            Impact factor:   1.513


  15 in total

1.  Intracavitary moderator balloon combined with (252)Cf brachytherapy and boron neutron capture therapy, improving dosimetry in brain tumour and infiltrations.

Authors:  S F Brandão; T P R Campos
Journal:  Br J Radiol       Date:  2015-04-30       Impact factor: 3.039

Review 2.  Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era.

Authors:  Minoru Suzuki
Journal:  Int J Clin Oncol       Date:  2019-06-05       Impact factor: 3.402

Review 3.  Boron neutron capture therapy for malignant brain tumors.

Authors:  Shin-Ichi Miyatake; Masahiko Wanibuchi; Naonori Hu; Koji Ono
Journal:  J Neurooncol       Date:  2020-07-16       Impact factor: 4.130

4.  Improvement of the boron neutron capture therapy (BNCT) by the previous administration of the histone deacetylase inhibitor sodium butyrate for the treatment of thyroid carcinoma.

Authors:  M Perona; C Rodríguez; M Carpano; L Thomasz; S Nievas; M Olivera; S Thorp; P Curotto; E Pozzi; S Kahl; M Pisarev; G Juvenal; A Dagrosa
Journal:  Radiat Environ Biophys       Date:  2013-05-01       Impact factor: 1.925

Review 5.  Boron Neutron Capture Therapy: Current Status and Challenges.

Authors:  Song Wang; Zhengchao Zhang; Lele Miao; Yumin Li
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

6.  FBPA PET in boron neutron capture therapy for cancer: prediction of (10)B concentration in the tumor and normal tissue in a rat xenograft model.

Authors:  Kohei Hanaoka; Tadashi Watabe; Sadahiro Naka; Yasukazu Kanai; Hayato Ikeda; Genki Horitsugi; Hiroki Kato; Kayako Isohashi; Eku Shimosegawa; Jun Hatazawa
Journal:  EJNMMI Res       Date:  2014-12-20       Impact factor: 3.138

7.  Radiobiological response of U251MG, CHO-K1 and V79 cell lines to accelerator-based boron neutron capture therapy.

Authors:  Eisuke Sato; Alexander Zaboronok; Tetsuya Yamamoto; Kei Nakai; Sergey Taskaev; Olga Volkova; Ludmila Mechetina; Alexander Taranin; Vladimir Kanygin; Tomonori Isobe; Bryan J Mathis; Akira Matsumura
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

8.  Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy.

Authors:  Koji Takeuchi; Yoshihide Hattori; Shinji Kawabata; Gen Futamura; Ryo Hiramatsu; Masahiko Wanibuchi; Hiroki Tanaka; Shin-Ichiro Masunaga; Koji Ono; Shin-Ichi Miyatake; Mitsunori Kirihata
Journal:  Cells       Date:  2020-06-25       Impact factor: 6.600

9.  Effect of bevacizumab treatment on p-boronophenylalanine distribution in murine tumor.

Authors:  Yong Liu; Minoru Suzuki; Shin-Ichiro Masunaga; Yi-Wei Chen; Genro Kashino; Hiroki Tanaka; Yoshinori Sakurai; Mitsunori Kirihata; Koji Ono
Journal:  J Radiat Res       Date:  2012-11-06       Impact factor: 2.724

Review 10.  Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.

Authors:  Rolf F Barth; M Graca H Vicente; Otto K Harling; W S Kiger; Kent J Riley; Peter J Binns; Franz M Wagner; Minoru Suzuki; Teruhito Aihara; Itsuro Kato; Shinji Kawabata
Journal:  Radiat Oncol       Date:  2012-08-29       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.